Methaderm

MetaDerm is a dermatology-focused biotechnology brand and platform developed by Haus Bioceuticals, a specialty pharmaceutical company based in Oklahoma City. The company utilizes a rigorous, evidence-based approach to develop therapeutic botanical formulations for chronic inflammatory skin conditions, most notably eczema (atopic dermatitis) and psoriasis. MetaDerm's core technology, a proprietary blend of 25 botanical extracts known as HAT01H, has demonstrated significant clinical efficacy in multiple trials, often outperforming standard topical corticosteroids and over-the-counter treatments. In 2019, the brand and its underlying technology were licensed to Procter & Gamble (P&G) through the P&G Ventures incubator and subsequently rebranded as Bodewell. Haus Bioceuticals continues to leverage its bioceutical platform to develop other natural medicines, including nanoparticle-delivered curcumin (NanoCur).